IP Library Granted Patent US 9,248,290
Granted Patent B2
US 9,248,290 · App. 14/451,362 · Granted Feb 2, 2016

Apparatus and methods for feedback-based nerve modulation

Inventor: Adi Mashiach (Tel Aviv, IL)
A61N1/36075A61B5/0031A61B5/11A61B5/113A61B5/4818A61B5/682A61F5/566A61N1/05A61N1/0504A61N1/0514A61N1/0526A61N1/0529A61N1/0548A61N1/0551A61N1/0553A61N1/36A61N1/3601A61N1/36003A61N1/3605A61N1/3606A61N1/3611A61N1/36057A61N1/36117A61N1/36125A61N1/36135A61N1/36146A61N1/3727A61N1/3756A61N1/3787A61N1/37211A61N1/37223A61N1/37229A61N1/37235A61N2/006A61N2/02A61B5/4519A61B5/6822A61B5/6833A61B5/6876A61B2562/164
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,248,290
App. No.
14/451,362
Granted
Feb 2, 2016
Kind
B2
Abstract

A device according to some embodiments may include a housing configured for location external to a body of a subject. The device may also include at least one processor associated with the housing and configured to communicate with a circuit implanted in the subject within proximity to a tongue of the subject, wherein the circuit is in electrical communication with at least one electrode, receive a physiological signal from the subject via the circuit, and send a control signal to the implanted circuit in response to the physiological signal, wherein the control signal is predetermined to activate neuromuscular tissue within the tongue.

Claims (21)

1. A hypertension therapy device for affecting blood pressure, the hypertension therapy device comprising:

a housing configured for location external to a body of a subject;

a first antenna configured to communicate with a second antenna associated with a circuit implanted in a blood vessel of the subject within proximity to at least one of a renal nerve, a baroreceptor, and a glossopharyngeal nerve, wherein the circuit is in electrical communication with at least one electrode;

a feedback circuit associated with the housing and configured to communicate with the first antenna;

at least one processor associated with the housing and further configured to:

communicate with the circuit through the first antenna;

receive a physiological signal from the subject;

send a control signal to the implanted circuit in response to the physiological signal, wherein the control signal is predetermined to modulate nerve tissue to affect blood pressure;

apply a sub-modulation control signal to the first antenna, the sub-modulation control signal inducing a secondary signal at the second antenna, the secondary signal in turn inducing a coupled signal at the first antenna;

receive, from the feedback circuit, the coupled signal generated by the first antenna; and

adjust the control signal based on the coupled signal received from the feedback circuit.

2. The hypertension therapy device of claim 1 , wherein the processor is configured to send the control signal within a response time between 1 millisecond and 10 minutes.

3. The hypertension therapy device of claim 1 , further comprising an antenna configured to transmit the control signal from the location outside of the subject's body to the second antenna associated with the implanted circuit.

4. The hypertension therapy device of claim 1 , wherein the physiological signal includes at least one aspect indicative of blood pressure of the subject.

5. The hypertension therapy device of claim 4 , wherein blood pressure is detected via a blood pressure sensor.

6. The hypertension therapy device of claim 1 , wherein the at least one processor is further configured to:

receive a signal, indicative of blood pressure, from a sensor remote from the implanted circuit.

7. The hypertension therapy device of claim 1 , wherein the at least one processor is further configured to determine a degree of blood pressure based on the physiological signal and vary a power level associated with the control signal based on the determined degree of the blood pressure.

8. The hypertension therapy device of claim 1 , wherein the at least one processor is further configured to determine a degree of blood pressure based on the physiological signal and vary a duration of the control signal based on the determined degree of the blood pressure.

9. The hypertension therapy device of claim 1 , wherein the at least one processor is further configured to receive a signal, indicative of blood pressure, from a sensor associated with the implanted circuit.

10. The hypertension therapy device of claim 1 , wherein the control signal is configured to perform at least one function chosen from the group consisting of stimulating the baroreceptor, down modulating the renal nerve, and stimulating the glossopharyngeal nerve.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: NYXOAH S.A.
To: MAN & SCIENCE S.A.
Reel/Frame 049305/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2018
From: MASHIACH, ADI
To: NYXOAH SA
Reel/Frame 047138/0568 →
Continuity (7)
Division 14041520 · Sep 30, 2013
Division 13629686 · Sep 28, 2012
Continuation In Part 12642866 · Dec 21, 2009
Continuation In Part 12581907 · Oct 20, 2009
Provisional Application 61541651 · Sep 30, 2011
Provisional Application 61657424 · Jun 8, 2012
Related Publication 20150032179A1 · Jan 29, 2015